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1INTRODUCTION
                      Hypertension is one of the leading causes of death and disability 
among adults all over the world. It remains the major risk factor for coronary, 
cerebral and peripheral vascular disease. Essential hypertension comprises more 
than 90% of hypertension1.
                      Hypertension is an emerging health problem in India. when 
majority of people come to know they have hypertension , they have already 
advanced in to stage with target  organ damage – fatal  stroke or  myocardial 
infarction  or  irreversible  renal  damage  unfortunately  even  in  developed 
countries like U.S.A. fifty million people are found to have hypertension. Of 
these  70%  are  aware  of  their  diagnosis  but  only  50%  are  receiving  only 
treatment and only 25% are under control2. 
                                 In addition to a primary increase in cardiac function  
propelled by overactive sympathetic nervous system, primary retention of salt 
and water by kidney, other factors contributing to hypertension are hereditary 
predisposition  and  high  sodium  and  low  potassium  intake  and  excretion. 
Positive  correlation  exists  with  high  sodium  intake  and  increase  in  blood 
pressure. 
                            Recent population based studies have shown a positive 
association between salt  excretion and blood pressure, however some studies 
have negated this association3.  Blood pressure was directly related to sodium 
intake and inversely and independently related to potassium intake.3
2                                            A recent study by Mohan et al 4 reports a prevalence 
of 20% in Chennai  in the CURES study.  Rural areas also showed a similar 
increase in prevalence of hypertension (~5-10%) although the rise was not as 
steep as in urban areas. Our present study was aimed at studying relationship of 
sodium and potassium excretion, and body mass index with blood pressure in 
normotensive and hypertensive people. 
                                   
3AIMS AND OBJECTIVES
1. To  study  24  hour  urine  sodium  excretion  in  newly  diagnosed 
hypertensive patients.
2.To correlate 24 hour urine sodium excretion with respect to their stages 
of hypertension as in Joint National Committee JNC VII and with respect 
to their body mass index.                         
                                    
4REVIEW OF LITERATURE
ESSENTIAL HYPERTENSION
                           An elevated arterial pressure is one of the most important 
public  health  problem  and  despite  widely  recognised  high  prevalence  and 
associated  danger ,  it  remains  moderately treated in majority  of patients .Its 
common ,readily detectable and usually easily treatable and if left untreated can 
lead to serious morbidity and mortality from cardiac, cerebrovascular, vascular 
and renal disease. Adequate hypertension control remains elusive because of the 
asymptomatic nature of disease for first  15-20 years even as it progressively 
damage  the  cardiovascular  system5.Although  our  understanding  of  the 
pathophysiology of hypertension has increased, in 90% to 95% of cases etiology 
is still unknown.
Definition and classification
                  Blood pressure is distributed in atypical bell shaped curve within 
overall population. As seen in multiple risk factor intervention trial (MRFIT), 
the long term risk for cardiovascular mortality rise progressively over the entire 
range of blood pressure with no threshold that clearly identifies the potential 
danger.  Therefore  the  definition  of  hypertension  is  somewhat  arbitrary  and 
usually taken as that level of pressure associated with doubling of long term 
risks.
5                                                    TABLE 1
JNC-7 CLASSIFICATION OF BLOOD PRESSURE FOR ADULTS ≥ 18 
YEARS.*
SI.NO CATEGORY
SYSTOLIC 
B.P 
(mm of Hg)
DIASTOLIC 
B.P 
(mm of Hg)
1
Normal <120 and <80
2 Prehypertension 120-139 or 80-89
3
Hypertension
Stage 1
140-159 or 90-109
Stage 2 ≥160 or ≥110
      
*[Source, JAMA 2003; 289:2560]
Prevalence
Cardiovascular  diseases  account  for  a  large  population  of  all  deaths  and 
disability worldwide. In 1990 there were 5.2 million deaths from cardiovascular 
diseases.
           Hypertension is directly responsible for 57% of all stroke deaths and 
24%  of  all  coronary  heart  disease  deaths.  This  fact  is  important  because 
6hypertension is a controllable disease and a 2mm Hg population-wide decrease 
prevent 151,000 strokes and 153,000 coronary heart disease deaths in india.6, 7
               The average blood pressure levels in china were systolic: 118±18mm 
Hg  and  diastolic:  76.6  ±  11mmHg  in  a  sample  of  10,076  urban  and  rural 
subjects 35-54 years of age. In India Gupta et al reported mean systolic blood 
pressure(men  :rural  127±14  urban,  125±17;women:rural  124±13,urban 
126±18)and diastolic blood pressure (men; rural 81±8 urban 81±9;women rural 
80±8  urban  81±12)  levels  in  western  Indian  urban  and  rural  subjects  aged 
≥20years8.Systolic  blood  pressure  has  increased   in  Indian  men  aged  40-49 
years from 123±11mmHg in 1959 to 128±17mmHg in 1995.9
               Recent studies among Indians have shown a high prevalence of 
hypertension  in  both  rural  and  urban  areas.10,11 The  prevalence  rate  of 
hypertension in India done by various study group is shown in Table 2 given in 
next page.
                                                      
7                                                       TABLE 2
 INDIAN HYPERTENSION PREVALENCE STUDIES (B.P >140mmHg.)
First author
Age
Group Place
Sample size Prevalence (%)
men women Men Women
Gupta R
1995
20-75 Jaipur 1415 797 29.5 33.5
Joseph A
2000
20-89 Trivandrum 76 130 31 41.2
Anand MP 
2000
30-60 Mumbai 1521 141 34.1* -
Mohan V
2000
20-70 Chennai 518 657 14* -
Gupta R
2002
20-75 Jaipur 550 573 36.4 37.5
Gupta PC
2004
18-60 Mumbai 40067 59522 43.8 44.5
*Gender specific data not available.
*Source J human hypertension 2004; 18:73-78
8                                Awareness status of hypertension in India is poor. In urban 
population of Mumbai there was very low awareness of hypertension and only 
6.1%males and 10.1% females were aware of hypertension in early 199012.In 
Jaipur also it has been reported that 11% of male and 16% female hypertensives 
were  aware  of  their  condition13.Higher  awareness  of  hypertension  has  been 
reported  among  more  educated  population  in  Kerala  and  among  parsis  in 
Mumbai14,15. In community dwelling individuals in Kerala (n=357, mean age70 
yrs) hypertension was present in 51.8%and 44.9% of the individuals were aware 
of  their  condition14.Bharucha  and Kuruvilla15 reported that  53% of  men  and 
44%were  aware  of  their  hypertensive  status,  although 905  have  their  blood 
pressure measurement  in past.  This level of awareness is similar  to reported 
from many  developed  countries  and  shows  that  within  India  there  is  wide 
variation in hypertensive awareness status.
Natural history and complication
                                                    The pathological hallmark of untreated 
hypertension is acceleration of atherosclerosis. The higher the blood pressure, 
the more likely cardiovascular diseases will develop prematurely. If untreated 
50% of hypertensive patient die of coronary artery disease and congestive heart 
failure, about 33%of stroke 10-15% of renal failure. A Meta analysis of nine 
major prospective studies shows a direct continuous and apparently independent 
9association of diastolic blood pressure with both coronary artery disease and 
stroke.16 
In general vascular complications of hypertension can be considered as either 
hypertensive or atherosclerotic.
I. Hypertensive complication.
1. Accelerated malignant phase.
2. Hemorrhagic stroke.
3. Congestive heart failure.
4. Nephrosclerosis.
5. Aortic dissection.
II. Atherosclerotic complication.
1. Coronary artery disease.
2. Sudden death
3. Arrhythmias.
4. Atherothrombotic stroke.
5. Peripheral vascular stroke.
 Overall cardiovascular risks 
10
            The  degree of  risks  from hypertension  can be categorized  with 
reasonable accuracy by taking into account,
1. The level of blood pressure.
2. The  biological  nature  of  hypertension  based  on  target  organ 
damage.
3.The co-existence of other cardiovascular risk factor 17.
The goal of anti-hypertensive therapy should not only be reduction of blood 
pressure  but  also  treating  other  risk  factors.  The  major  cardiovascular  risks 
factors indicated in JNC-7 report are
1) Hypertension. 
2) Cigarette.
3) Obesity.
4) Physical activity.
5) Dyslipidemia.
6)Diabetes mellitus.
7) Microalbuminuria or estimated glomerular filteration rate<60 ml/ 
min.
8)Age (>55 for men,>65 for women).
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9)Family  history  of  premature  cardiovascular  disease  (<55  for 
men,<65 for women).
  Systolic hypertension and Pulse pressure
                       Systolic blood pressure rises in a linear fashion with age, whereas 
diastolic blood pressure increases until age of 50 then levels off and began to 
fall .Isolated systolic hypertension is more common in younger subjects while 
isolated  diastolic  hypertension  is  more  common  in  elderly.  The  underlying 
pathology process is loss of arterial tissue, which means that the pressure was 
created by left ventricular contraction, can no longer be dammed by aorta and 
major vessels.
                    Systolic blood pressure is a better predictor of cardiovascular 
system  risk  and  isolated  systolic  hypertension  is  now  recognised  to  be 
independent risk factor of cardiovascular disease .A wide pulse pressure has a 
similar influence on prognosis18.
Gender differences
           Hypertension is an important risk factor for cardiovascular disease in 
women. Although premenopausal women have lower blood pressure than age 
matched men, the prevalence of hypertension is higher in women than men after 
age of 65.Obesity is more common in middle aged and older women and is 
likely  to  contribute  to  cross  over  in  prevalence.  Oral  contraceptive  pills 
12
increases  risk of  hypertension in  younger  women.  The  ratio of  hypertension 
frequency in women versus men increases from 0.6 to 0.7 at age 30 to 1.1 to 1.2 
at the age of 65 yrs.
Hypertension in Black population
                         Hypertension is common in black than in white and more 
common  in  urban  than  in  rural  blacks.  Black  individuals  have  a  higher 
incidence of salt sensitive hypertension than white individuals and retain more 
sodium leading to expanded plasma volumes and lower plasma rennin activity. 
The complication of hypertension tends to be different in blacks with a higher 
incidence of left ventricular hypertrophy, stroke, renal failure and lower risk of 
coronary artery disease and is due to severity of hypertension in blacks and 
lower risk of coronary artery disease than white is due to more favourable lipid 
profiles.
MECHANISM OF PRIMARY HYPERTENSION
                            No single specific cause is referred to as primary in preference 
to essential. Blood pressure is product of cardiac output and peripheral vascular 
resistance(B.P=C.O*PVR).since  persistent  hypertension  can  develop  only  in 
response  to  an  increase  in  cardiac  output  or  a  rise  in  peripheral  resistance 
,defects may be present in one or more of the multiple factors that affect these 
two forces. This can be described under the following headings
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1. Non renal factors
2. Renal factors.
1) NON RENAL FACTORS
               Primary hypertension is a complex multifactorial and polygenic 
disorder  that  results  from  an  interaction  between  an  individual’s  genetic 
background and various environmental factors.
Genetic predisposition
                             In studies of twins and family members in which degree of 
familial aggregation of blood pressure level is compared with the closeness of 
genetic sharing, the genetic contributions have been estimated to range from 
30% to 60% 19. Harrap suggested that the average population blood pressure is 
determined  by  the  environment  but  the  blood  pressure  rank  within  the 
distribution is decided largely by genes.20
                                          Epidemiological data suggest that for population 
variability  in  blood  pressure  genetic  factors  contribute  30-35%,  common 
household  environment  about  10-15%  and  non-familial  factors  for  the 
remaining 50-55%.21
                                     If genetic markers of a predisposition for the  
development  of  hypertension  are  found,  then  specific  environmental 
manipulations could then be directed toward the susceptible subject22.Pratt, from 
14
his observations of  bimodal  distributions of blood pressure in some families 
with hypertensive subjects, proposed autosomal dominant mode of inheritance. 
Pickering  proposed  that  blood  pressure  is  a  quantitative  trait  with  genetic 
contribution which is polygenic.
    Genome wide scanning strategy in sib-pairs  has identified chromosomal 
regions on chromosomes 6, 5, 12, 15 which showed significant linkage to genes 
that  influences  inter  individual  blood  pressure  variation.  There  are  several 
candidate genes within the identified group23.
                                   Polymorphism of genes involving RAS system,  
aldosterone  synthesis  and  adrenergic  receptors  has  been  noted  to  be  more 
common in the hypertensive than normotensive patients.24 Genetic abnormalities 
may  be  monogenic  in  some  rare  forms  of  hypertension  like  glucocorticoid 
remediable  aldosteronism,  Liddle  syndrome,  and  apparent  mineralocorticoid 
excess.25 
Fetal environment
                         Low birth weight, as a consequence of fetal under nutrition is 
followed by an increased incidence of high blood pressure later in life with an 
overall estimate that a 1kg lower birth weight is associated with a 2 to4mmHg 
higher systolic blood pressure in adulthood26.Brenner & Chertow hypothesized 
that a decreased number of nephrons from intra uterine growth retardation could 
15
very  well  serve  as  a  permanent  irreparable  defect  that  eventuates  in 
hypertension.27
Vascular remodelling
                     A number of factors increase peripheral resistance by both 
functional  contraction  and  vascular  remodelling  and  hypertrophy.  Multiple 
vasoactive  substances  act  as  pressure-growth  promoters  resulting  in  both 
vascular  contraction  and  hypertrophy  simultaneously,  but  perpetuation  of 
hypertension involves hypertrophy. Lever and Harrap28  postulated that primary 
hypertension has two mechanisms similar to secondary hypertension a)a growth 
promoting process in children and b)a self perpetuating mechanism in adults.
Neurohumoral causes of primary hypertension
                             A large number of circulatory hormones and locally acting 
substances may be involved in the development of hypertension which causes 
hypertension  by  vascular  hypertrophy,  capillary  rarefaction  and  unpaired 
microvascular dilation29.
     A. Sympathetic nervous hyperactivity 
                              Young hypertensives tend to have increased levels of  
circulating  catecholamines  ,augmented  sympathetic  nerve  traffic  in  muscles, 
faster heart rate and heightened vascular reactivity to alpha adrenergic agonists30 
.These changes could raise the blood pressure  in a number of ways either alone 
16
or in concert with stimulation of rennin release by catecholamines or by causing 
arteriolar and venous constriction or by increasing cardiac output or by altering 
the normal renal pressure-volume relationship.
      B. Renin angiotensin system
                                 Both as a direct pressor and as a growth promoter renin  
angiotensin system may be also involved in pathogenesis of hypertension. All 
functions of renin are mediated through the angiotensin II. This system is the 
primary  stimulus  for  the  secretion  of  aldosterone  and  hence  mediates 
mineralocorticoid  responses  to  varying  sodium  intake  and  volume  overload 
when sodium intake is reduced or effective plasma volume shrinks the increase 
in  renin-  angiotensin  II  stimulates  aldosterone  secretion  which  in  turn  is 
responsible for a portion of the enhanced renal retention of sodium and water.
                     When large proportions of hypertensives are surveyed, only about 
30  percent  have  low plasma  renin  activity  levels,  whereas  50  percent  have 
normal levels and the remaining 20 percent have high levels 31
      Normal and high renin hypertension.
Some persons with primary hypertension have normal or high renin activity. 
The  concept  of  “nephron  heterogencity”32 described  by  Sealy  &  collegues, 
assumes  a  mixture  of  normal  and  ischemic  nephrons  caused  by  afferent 
arteriolar narrowing. Excess renin from the ischemic nephrons could raise the 
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total  blood  renin  levels  to  varying  degrees  and  cause  high  renin  levels  in 
patients with primary hypertension.
     C. Hyperinsulinemia/ Insulin resistance
                    An association between hypertension and hyperinsulinemia has 
been recognized for many years,  particularly with accompanying obesity but 
also in about 20% of non-obese hypertensive patients33.The hyperinsulinemia of 
hypertension  arises  as  a  consequence  of  resistance  to  effects  of  insulin  on 
peripheral glucose utilisation. This association does not apply to pima Indians 
but it has been found in blacks, Asians and as well as whites. The impairment of 
the  peripheral  actions  of  the  insulin  results  from  a  defect  in  the  usual 
vasodilatory  effect  of  insulin  mediated  through  increased  synthesis  of  nitric 
oxide, which normally counters the multiple pressors effects of insulin34.
                                            These pressor effects include activation of  
sympathetic activity, a trophic action on vascular hypertrophy, and increased 
renal sodium reabsorption resulting in a rise in blood pressure that may be either 
a primary cause of  hypertension or, atleast, a secondary potentiator.
      D. Endothelial cell dysfunction
The  endothelium is  now  known  to  be  the  source  of  multiple  relaxing  and 
contracting substances of which niric oxide is an important  vasodilator35.The 
impairement of normal vasodilation in the insulin resistance syndrome has been 
18
shown to involve failure to synthesize the normal endothelium derived relaxing 
factor (NO).     
      Nitric oxide
                Hypertensive  patients  have  been shown to  have a  reduced 
vasodilatory response to various stimuli of nitric oxide release that appears to be 
independent  of  the etiology of  the hypertension and the degree of the gross 
vascular structural alteration. Impaired nitric oxide mediated vasodilation may 
promote  abnormal  vascular  remodelling  and may  be  involved in  the  greater 
propensity for vascular damage in blacks than whites. 
       Endothelin
               Endothelin-1 causes pronounced and prolonged vasoconstriction and 
because blockade of its receptors improves endothelium dependent vasodilation 
in hypertensives patients.36
    E) Minerals 
             Excess of lead and changing ratios among dietary sodium, potassium, 
calcium  and  magnesium  have  also  been  postulated  in  the  pathogenesis  of 
primary hypertension.37
2) RENAL RETENTION OF EXCESS DIETARY SODIUM.
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           A considerable amount of circumstantial evidence supports a role for 
sodium in the  genesis  of  hypertension.  To induce  hypertension  some of  the 
excess sodium must be retained by the kidneys .such retention could arise in a 
number of ways.
1. Nephron heterogeneity, described as the presence of a sub population 
of  nephrons  that  is  ischemic  either  from  afferent  arteriolar 
vasoconstriction or from an intrinsic narrowing of lumen. Renin secretion 
from this subgroup of nephrons is tonically elevated. This increased renin 
secretion  then  interferes  with  capacity  of  normal  nephrons  to  excrete 
sodium.
2.  A resetting  of  the  normal  pressure  natriuresis  relationship-  Guyton 
hypothesis.38
3. An acquired inhibitor of the sodium pump or other abnormalities in 
sodium pump or other abnormalities in sodium transport.39
4. Defensive responsiveness to atrial natriuretic hormone.40
ASSOCIATION OF HYPERTENSION WITH OTHER 
CONDITIONS
1) PHYSICAL ACTIVITY
          Physical fitness may help prevent hypertension and persons who 
are  already  hypertensive  may  lower  their  blood  pressure  by  regular 
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isotonic exercise. The relationship may involve insulin resistance because 
an  increased  resistance  was  coupled  with  low  physical  fitness  in 
normotensive men with family history of hypertension.
2)  ALCOHOL
     Alcohol in larger amounts (more than 2 portions a day and more so 
when drunk in binges) increases blood pressure and arterial stiffness. The 
pressure effect of larger amount of alcohol reflects an increase in cardiac 
output and heart rate, possibly a consequence of increased sympathetic 
nerve  activity.  Alcohol  also  alters  cell  membranes  and  allows  more 
calcium to enter, perhaps by inhibition of sodium transport.
                                      Alcohol in small amounts (less than 1or 2 usual  
portions  a  day  provides  protection  from  coronary  disease,  congestive 
heart  failure,  stroke  and  dementia41.And  atleast  in  women,  reduces 
incidence of hypertension42.The reduction in coronary disease in persons 
who  ingest  small  amount  of  alcohol  reflect  an  improvement  in  lipid 
profile,  a  reduction  in  factors  that  encourage  thrombosis,  and  a 
improvement in insulin sensitivity.
                                Framingham study showed small overall correlation 
between  alcohol  intake  and  blood  pressure,  but  prevalence  of 
hypertension was about 2 tiers higher among persons drinking 60 ounce 
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or more of ethyl alcohol per month than among those drinking less than 
30 ounce per month.43
3)SMOKING 
Cigarette  smoking  raises  blood  pressure,  probably  through  nicotine 
induced release of nor- epinephrine  from adrenergic nerve endings. In 
addition, smoking causes an acute and marked reduction in radial artery 
compliance independant of the increase in blood pressure. When smokers 
quit,a  rise  in  blood  pressure  may  occur,  probably  reflecting  again  on 
weight. Numerous studies have shown that smokers are thinner than non 
smokers and that smoking reduces weight. However they will have larger 
waist hip ratio than non smokers44.
4)  HEMATOLOGICAL FINDINGS.
                      Higher hematocrit are found in hypertensive persons and 
are  associated  with  abnormal  left  ventricular  filling  on 
echocardiography45.whole blood viscosity is increased by about 10% in 
persons with untreated mild hypertension, comparable to the increase in 
their  peripheral  resistance46.Pseudo  or  stress  polycythemia  with  high 
hematocrit and increased blood viscosity but contracted plasma volume, 
as well as normal red cell mass and serum erythropoietin levels are found 
in  hypertension.  High  white  blood  cells  count  is  predictive  of 
hypertension.47   
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5) HYPERURICEMIA
          Hyperuricemia  is  present  in 25% individuals  with untreated 
hypertension  and  in  more  than  75%  of  patients  with  malignant 
hypertension  which  are  about  5  times  the  frequency  found  in 
normotensive persons48.Hyperuricemia probably reflects decreased renal 
blood flow, presumably a reflection of nephrosclerosis.
 6) SLEEP APNOEA.
                  Snoring and sleep apnoea are often associated with 
hypertension, which may in turn be induced by the increased sympathetic 
activity  and  endothelium  release  in  response  to  hypoxemia  during 
apnoea.49
7) HYPERCHOLESTROLEMIA
                          Hypercholesterolemia frequently co-exists with 
hypertension, at least in part because it impairs endothelium- dependent 
vasodilatation.  Lipid  lowering  therapy  restores  the  bio-availability  of 
nitric-oxide, reduces arterial stiffness, and lowers blood pressure.50
8) OBESITY
23
               The  majority  of  patients  with high blood pressure  are 
overweight and hypertension is about 6 times more common than its in 
lean subjects.51
          A 10 kg higher body weight is associated with 3mm Hg higher 
systolic and 2.3mm Hg higher diastolic blood pressure. These increases 
translate into an estimated 12% increase in the risk of coronary artery 
disease and 2.24% increase in the risk of stroke.
                    Body mass index in widely used as a correlation with excess 
body fat or adiposity but it does not convey information on required fat 
distribution.  Body  fat  distribution  plays  a  role  as  a  risk  factor  for 
hypertension. An  increase in waist hip ratio(WHR)>0.95 in male and 0.8 
in  female  is  an  independent  risk  factor   for  the  development  of 
hypertension and is independently associated with hypertriglyceride and 
increased apoprotein.The waist circumference may be the better indicator 
of visceral fat than waist hip ratio.
HIP CIRCUMFERENCE- it is measured at the point of one third of the 
distance between the anterior superior iliac spine and patella.
WAIST CIRCUMFERENCE-it is measured half way between superior 
iliac crest and rib cage in mid-axillary line. It correlates well with systolic 
blood pressure and diabetes mellitus.
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                 But to prevent wide gender differences we can use body mass 
index to compare obesity and hypertension.
         BODY MASS INDEX=WEIGHT IN KG/HEIGHT IN m2
TABLE-III
Proposed Classification of Body Mass Index In Adult Asians52
Classification BMI (kg/m2)
Underweight <18.5
Normal range 18.5-22.9
Overweight 23
At risk 23-24.9
Obese I 25-29
Obese II >30
* Source Am J Clin Nutr, 2000; 72:1067-1068
Metabolic Syndrome
                                     According to ATP III guidelines metabolic syndrome is 
defined  as  a  cluster  of  cardiovascular  risks  in  a  sliver  individual  –normally 
hypertension,  diabetes  mellitus,  and  abdominal  obesity,  low HDL increased 
TGL, procoagulant tendency and increased small LDL. 
                          Obese individuals with high waist hip ratio have high incidence 
of hypertension than do with low waist hip ratio53. Visceral obesity is a striking 
risk factor for hypertension although body mass index is a strong determinant of 
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blood pressure,  a visceral distribution of fat has an even greater relationship 
with development of hypertension54.
Sodium metabolism and Sodium balance
         Major intracellular particles are sodium and its accompanying anion 
chloride  and  bicarbonate,  whereas  potassium  and  organic  phosphate  esters 
(ATP, creatine phosphate and phospholipids) are the predominant intracellular 
fluid  osmoles.  Since  sodium  is  largely  restricted  to  the  extracellular 
compartment, total body sodium content is a reflection of the extracellular fluid 
volume.
               Sodium is actively pumped out of the cells by the NA+K+ATP ase 
pump. As a result 85 to 95 % of all sodium is extracellular and extracellular 
fluid volume is a reflection of total body sodium content .Changes in sodium 
concentration  generally  reflects  disturbed  water  homeostasis,  where  as 
alteration  in  sodium  content  are  manifested  as  extracellular  fluid  volume 
contraction or expansion and imply abnormal sodium balance.
Sodium intake  
                An individual eating a typical western diet consumes approximately 
150 m mol of sodium chloride daily this normally exceeds basal requirements 
therefore  dietary  intake  of  sodium  results  in  extracellular  fluid  volume 
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expansion which in turn promotes enhanced renal sodium excretion to maintain 
steady state sodium balance.
Sodium excretion
           The regulation of sodium excretion is multifactorial and is the major 
determinant  of  sodium  balance.  Tubule  sodium  absorption  is  the  major 
regulatory  mechanism  controlling  sodium  excretion.  Almost  two  thirds  of 
filtered  sodium  is  reabsorbed  in  proximal  convoluted  tubule.  Further 
reabsorption (35-30%) occurs in the thick ascending limb of loop of henle via 
apical  Na+ K+3Cl- co  transporter.  Distal  convoluted  tubule  reabsorption  of 
sodium(5%)is  mediated  by  thiazides  sensitive  sodium  chloride 
cotransporter.Final  sodium reabsorption occurs  in  the cortical  and medullary 
collecting  ducts,  the  amount  excreted  being reasonably  equal  to  the  amount 
ingested per day.
SODIUM AND HYPERTENSION
1. Sympathetic Nervous System and Sodium Handling
              The renal sympathetic nervous system directly stimulates the sodium 
reabsorption  and  renin  release  from the  juxta  glomerular  apparatus.  Several 
studies have linked sympathetic nervous system hyperactivity with greater than 
normal increase in blood pressure in response to a given sodium load55. Most 
authorities believe that mechanism by which the kidney causes hypertension is 
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impairment in excretion of sodium56,  57. This impairment may be attributed to 
genetic changes in various sodium exchangers in the proximal and distal tubules 
resulting in altered response to stimulation by the   sympathetic nervous system 
and renin angiotensin –aldosterone system.
                     Interventional studies with sodium restriction and loading have 
revealed that the blood pressure responses in many hypertensives patients are 
salt sensitive .Salt loading of patients with essential hypertension results in an 
increase in blood pressure and in a net body sodium accumulation.
2.An increase in cytosolic free sodium concentration in cells of hypertensives 
compared  with  age  and  sex  matched  normotensive  controls  have  been 
documented58  .This results from altered activity of the Na+k+  antiporter and the 
Na+ Li+  counter  transporter  the  increase  in  intracellular  sodium  is  highly 
correlated with presence of an elevated diastolic blood pressure.
3.  Most  patients  with  essential  hypertension  have  a  defect  in  the  pressure 
natriuresis curve, in which higher systemic pressures are required to excrete a 
sodium load.59
 4. Another mechanism for decreased sodium excretion in patients with essential 
hypertension is enhancement of tubuloglomerular feedback.58
5.  Alterations  in  intrarenal  vasoactive  mediators  may  be  involved  in  the 
impairment of sodium excretion in patients with essential hypertension. There 
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may be low levels of renal vasodilators such as prostaglandins, dopamine and 
nitric  oxide  as  well  as  elevated  levels  of  renal  vasoconstrictors  such  as 
angiotensin II  and adenosine and increased activity  of the renal  sympathetic 
nervous system .Alterations in the levels of these agents could contribute to net 
sodium reabsorption because of their direct effects on tubular sodium transport.
Potassium balance
         Potassium is the major intracellular cation. The normal plasma potassium 
concentration  is  3.5  to  5  mmol  /l  whereas  that  inside  the  cell  is  about  150 
mmol / l .therefore the amount of potassium in the extracellular fluid is less than 
2%of total body potassium content.  This is due to the principal result of the 
resting membrane potential and is crucial for normal neuromuscular function 
the basolateral NA+K+ATPase pump actively transports potassium in and out of 
the  cell  in  a  2:3  ratio  and  the  passively  outward  diffusion  of  potassium is 
quantitatively the most  important  factor  that  generates the resting membrane 
potential.
Potassium intake
                       The intake of individuals on an average western diet is 40 to 120 
mmol/day.90% of which is absorbed by the gastrointestinal tract .immediately 
following meal most of the absorbed potassium enters cells as a result of the 
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initial  elevation in the plasma potassium concentration and facilitated by the 
insulin release and basal catecholamine levels.
Potassium excretion
                  Renal excretion is the major route of elimination of dietary and other 
sources of excess potassium 90% of the filtered potassium is reabsorbed by the 
proximal  convoluted  tubule  and  the  loop  of  henle.  Proximally  potassium is 
reabsorbed passively with sodium and water, whereas the luminal Na+K+2CL- 
co transporter mediates potassium uptake in the thick ascending limb of loop of 
henle, therefore potassium delivery to the distal nephron approximates dietary 
intake. The cell responsible for potassium secretion in the late distal convoluted 
tubule and cortical collecting duct is the principal cell.
                                                                    
MATERIALS AND METHODS
SETTING   : This study was carried out in Hypertension outpatient department 
and wards of Department of General Medicine, Government Stanley medical 
college, Chennai.
STUDY DESIGN:    Analytical study.
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SAMPLE POPULATION:     100 CASES, 70 cases + 30 controls
PERIOD OF STUDY:   October 2008 to October 2009.          
ETHICAL COMMITTEE APPROVAL: The present study was approved by 
the ethical committee.
MATERIAL AND METHODS
           Seventy newly diagnosed hypertensive patients as per criteria of JNC VII 
report. Controls were selected from the attendants accompanying cases except 
siblings.  
Inclusion criteria
1. Newly diagnosed hypertension patients not started on treatment. 
2. Hypertension as per criteria of JNC VII report i.e. blood Pressure 140/90
    mmHg least at three different occasions.
3. Patients age above 18 years.
4. Both sexes were included.
Exclusion criteria
1. Patients of secondary hypertension 
2. Patients on non-steroidal anti-inflammatory agents, diuretics.
3. Patients with congestive cardiac failure.
4. Patients with malignant hypertension.
5. Females on oral contraceptive medication.
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6. Hypertensive patients on treatment
Control group
1. Same age and sex.
2. BP lower than the specified for hypertensive group
Consent
          The study group thus identified was informed about the nature of the 
study and willing participants were included in the study after getting written 
informed consent from them. 
Study subject and controls 
              Seventy newly diagnosed patients of hypertension from outpatient 
department and wards of Government Stanley medical college for the period of 
study,  comprised  the  study  group.  Thirty  controls  were  selected  from  the 
attendants of hypertensive patients living in the same environment other than 
their siblings. Incidentally in our study cases fall within the age group of 40 to 
60 years, so controls were selected in the same age group.
Details of the study subjects
             A detailed  history  of  all  subjects  especially  family  history  of 
hypertension, cardiovascular disease, renal disease, diabetes mellitus, history of 
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weight gain, sodium intake, alcohol use and symptoms suggestive of secondary 
hypertension.  History of  other  cardiovascular  risk  factors  (including obesity, 
smoking,  hyperlipidemia,  diabetes)  and  all  prescribed  and  over  the  counter 
medications.  All  subjects  were  subjected  to  thorough  physical  examination 
which  included  all  peripheral  pulses  including  carotids  to  rule  out 
atherosclerosis.
              Examination of extremities  for oedema, diminished and absent 
peripheral  arterial  pulsations,  measurement  of  body  mass  index  (BMI) 
calculated  by  weight/height2  (kg/m2),waist  and  hip  circumferences  were 
measured optic fundoscopic examination for any hypertensive changes, neck for 
distended veins, thyromegaly, cardiovascular, respiratory, abdominal and CNS 
examination.
                          Atleast three blood pressure measurements with same standard 
mercury  sphygmomanometer  and  Littman’s  stethoscope  in  both  supine  and 
standing in both the arms were measured. 
GUIDELINES FOR MEASURING BLOOD PRESSURE 
I .CONDITIONS FOR THE PATIENT
A POSTURE
1.Patient should sit with back supported for about 5 minutes before taking a 
reading and the arm should be resting at heart height on a table, or other suitable 
property.
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2. For diabetics and patients aged above 65 check postural changes by taking 
blood pressure immediately and two minutes after standing.
B. CIRCUMSTANCES
1. Do not move while taking reading.
2.Do not  smoke  for  about  30  minutes  before  taking  a  reading.  Do  not 
consume any caffeine (coffee, soda, tea etc.) for about 30 minutes before 
taking a reading. Preferably do not to eat for at least 30 minutes before 
taking reading.
3. Have an empty bladder.
4. Home readings taken under various circumstances and 24 hr ambulatory 
recordings may be preferable.
II EQUIPMENT
A)CUFF SIZE:
         The bladder should encircle and cover 2/3 of arm length. If not, place the 
bladder over the brachial artery, if bladder is small, high readings may result.
B)MANOMETER:
     Sphygmomanometer is used for measuring the blood pressure.
3) TECHNIQUE
  A)  NUMBER OF READINGS.
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a. Three readings are taken for each patient and the average of three 
readings is taken.
b.Initially, blood pressure is measured in both arms, if blood pressure 
differs, higher blood pressure reading is taken.
c. If arm pressure is elevated, blood pressure is measured in one leg, 
particularly in patients below age 30.
B) PERFORMANCE.
                The bladder is inflated quickly to a pressure 20mmhg above the 
systolic,  as  recognized  by  disappearance  of  a  radial  pulse.  The  bladder  is 
deflated  3mm Hg every  second.  The  systolic  blood pressure  corresponds  to 
appearance of korotkoff sounds and the diastolic blood pressure corresponds to 
the disappearance of korotkoff sounds(phase 5) .If korotkoff sounds are weak, 
have the patients raise the arm, open and close hand 5 to 10 times, after which 
bladder should be inflated quickly.
C)RECORDING
           The blood pressure, patient position, the arm cuff size (eg.140/90,seated, 
right arm,  large adult cuff,)are noted.
Urine albumin, sugar, microscopy and pH were done for all the subjects. A 12 
lead ECG, ultrasonogram abdomen and chest x-ray were also taken.
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Overnight  (12hr)  fasting  blood  sugar  and urea  was  done  by  using  diacetlyl 
monoxime (DAM) technique. Serum creatinine was estimated using COBAS 
auto  analyser.  Serum  sodium  and  potassium  was  estimated  using  flame 
emission photometric method in an accurate manner.
 TWENTY FOUR HOUR URINE STUDY
         A single measurement of 24-h sodium excretion is a valid estimate of 
dietary sodium intake  61. The  24-h urine collection was  considered the most 
reliable method to evaluate sodium and potassium intake amounts 62, 63.
                     All subjects were given thorough instructions about how to collect 
the 24hour urine specimen both orally and in written form. Sodium, potassium, 
protein and creatinine levels were estimated. Volume is accurately measured. 
The sample was analysed for accuracy with creatinine values. [Ref. Value 24 
hrs Urine: MEN: 1040 - 2350 mg/24 Hrs WOMEN: 740 - 1570 mg/24 Hrs] and 
volume [>500 ml]. In our study all the samples collected were accurate. Hitachi 
902 Multichannel analyser was used to measure electrolytes and Jaffe’s method 
is used to measure creatinine.
Definitions used in present study
Essential hypertension
     Hypertension was defined in accordance with JNC VII report as systolic 
blood pressure 140 mm hg and above and or diastolic blood pressure 90 mm hg 
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and  above  .The  diagnosis  of  essential  hypertension  is  based  on  the  clinical 
examination and laboratory  investigations . As the cases were newly diagnosed 
the duration of hypertension is not known. 
Sodium and potassium normal values 
The normal range for sodium was from 136 to 146 mmol /l .The normal range 
for  serum potassium is  from 3.5  to  5.1  mmol/l  .The  24  hour  urine  sodium 
normal value is 40 - 220 mEq/24 hours and 24 hr urine potassium normal value 
is 25 - 125 mEq /24 hrs.
Obesity
                       According to proposed classification of weight by B.M.I in adult  
Asians, the patients with a BMI less than 18.5 were classified as underweight ,
18.5 to 22.9 were classified as normal >23 were classified as overweight and 
>35 were classified as obese 
Diabetes mellitus 
                    Patients with fasting glucose > 126mg/dl or two hour plasma 
glucose >200 mg/dl or with symptoms of diabetes plus RBS>200 mg/dl were 
considered to be diabetic. 
Left ventricular hypertrophy 
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Based on the Electrocardiographic findings which satisfy either the Sokolow 
lyon criteria or cornell voltage criteria.  64, 65
Conflict of interest 
           There was no conflict of interest
 Financial support 
          No.
Limitations 
1. Arterial blood gas analysis was not done due to financial limitations.
2. Renal handling of sodium was not attempted as it was beyond the scope of 
the study.
3. Body water content was not associated with which may alter the level of 
sodium and potassium.
4. Tissue sodium and potassium was not measured. 
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5.  Hormones  related  sodium  and  potassium  handling  in  kidney  was  not 
measured 
6.  The  salt  intake  of  the  patient  could  not  be  measured  quantitatively  and 
qualitatively because of social constraints.
7. A single measurement of 24-h sodium excretion is made because
 of social and financial constraints.
Statistical analysis 
                    The collected data was entered in Microsoft excel spread sheet and 
analysed  statistically.  Student  t  values  were  applied  for  significance. 
Significance was considered if p value was below 0.05[95% confidence]. 
                    RESULTS AND OBSERVATIONS
       The total number of subjects included in this study was 100.Among these 
100 subjects 70 were cases and 30 were controls. Among cases 26 were stage I 
and 44 were stage II hypertension according to JNC VII.
      Analysis of cases and controls with respect to age
                The age of the subjects in the study group ranged from 40 to 60 years.  
The mean and standard deviation for cases and control were 53.7±4.88 and 51.9 
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± 4.89 respectively. The study group and the control group did not differ from 
each other statistically with reference to age. (Fig-1)
                                                Table IV
Distribution of cases and controls in relation to age
Age group Cases Control
No % No %
41-50 17 24 14 46
51-60 53 76 16 54
Mean 53.7 51.9
S.D 4.88 4.89
 
FIG 1
Distribution of cases and controls according to age
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 Among the cases the the mean and standard deviation of age for stage I and 
stage II hypertensives  were  52.9± 5.12 and 54.2± 4.72 respectively .so there is 
no difference statistically between two groups statistically with reference to age. 
                                               TABLE - V  
STAGE I STAGE II
MEAN 52.9 54.2
STANDARD 
DEVIATION
5.12 4.72
Distribution of cases and controls in relation to gender
   Among cases there were 38 males and 32 females. Among controls there were 
20 males and 10 females. This is shown in TABLE-VI given below 
                                        TABLE VI
Sex Cases Control
No % No %
Males 38 54 20 67
Females 32 46 10 33
Total 70 100 30 100
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The group of cases comprises of both stage I and stage II hypertensives. Among 
stage I hypertensive cases there were 14 males and 12 females. Among stage II 
hypertensives there were 24 males and 20 females .This is shown in TABLE-
VII.
Distribution of stage I and stage II hypertensives in 
relation to gender
TABLE VII
Sex STAGE I STAGE II
No % No %
Males 14 54 24 55
Females 12 46 20 45
Total 26 100 44 100
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Analysis of cases and controls with respect to 
Body mass index
         49 % of cases were obese whereas among control group only 3% were 
obese. The details are given in TABLE VIII (FIG-2) shown below
TABLE VIII
B.M.I Cases Control
No % No %
Underweight < 18.5 5 7 3 10
Normal 18.5-22.9 22 31 20 67
Overweight 23-24.9 9 13 6 20
Obese > 25 34 49 3 3
Total 70 100 30 100
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FIG -2
Distribution of cases and controls with respect to their 
Body mass 
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Distribution of stage I and stage II hypertensives with respect to 
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TABLE IX
B.M.I stage I stage II
No % No %
Underweight < 18.5 1 4 4 9
Normal 18.5-22.9 11 42 11 25
Overweight 23-24.9 3 12 6 14
Obese > 25 11 42 23 52
Total 26 100 44 100
 
Body Mass Index [B.M.I] among stage I and stage II hypertensives does not 
differ significantly (TABLE-IX).
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Body Mass Index [B.M.I] among cases and control
                 The mean and standard deviation of B.M.I among cases and control 
were shown below TABLE X shown below (FIG-3)
                                         TABLE X
B.M.I CASES CONTROL
MEAN 24 21.3
S.D 3.15 2.14
                                                P value = 0.00004
This  table  shows  that  there  is  a  statistically  significant  difference  in  B.M.I 
among cases and control.   
FIG-3
Body Mass Index [B.M.I] among cases and control
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hypertensives
                                                TABLE XI
B.M.I STAGE I STAGE II
MEAN 23.91 24.15
S.D 3.41 3.61
                                                    P VALUE = 0.78 
Though there appears to be a difference in Body Mass Index [BMI] between 
stage I and stage II hypertensives it was not statistically significant. (TABLE – 
XI).
Body Mass Index [B.M.I] among cases controls with 
respect to gender
            The table XII below shows the Body Mass Index [B.M.I] among the 
cases and controls with respect to gender.
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TABLE XII
B.M.I Case Control P VALUE
Male 24.19 ± 3.62 20.90 ± 2.07 0.0004
Female 23.92 ± 3.44 22.2 ± 2.1 0.14
 The  mean  of  Body  Mass  Index  among  male  cases  are  24.19  which  is 
significantly  higher  statistically  compared  male  controls.  There  is  no 
statistically significant difference in Body Mass Index [B.M.I] among female 
cases and controls. 
Analysis of presenting symptoms
The cases both stage I and stage II hypertensives were analysed with respect to 
their presenting symptom. This is shown in TABLE XIII given below 
TABLE XIII
Symptoms stage I stage II
No % No %
Giddiness 12 46 12 27
Headache 7 27 16 36
Chest pain 3 12 6 14
Palpitation 4 5 8 18
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Dyspnoea 0 0 2 5
Total 26 100 44 100
Headache and giddiness were the more common symptoms of the cases in our 
study both stage I and stage II hypertensives.
 Distribution of systolic and diastolic blood pressure 
As the raised blood pressure was the nature of the disease taken in to study it 
was not statistically analysed. The distribution of systolic and diastolic blood 
pressure among cases and controls is shown in TABLE XIV given below 
TABLE XIV
BLOOD PRESSURE
CASES
MEAN ± S.D
CONTROL
MEAN ± S.D
Systolic 167.82±18.50 106.9±6.46
Diastolic 104.51±8.51 71.6±4.32
 
Distribution of systolic and diastolic blood pressure among 
stage I and stage II hypertensives
   The distribution of systolic and diastolic blood pressure among stage I and 
stage II hypertensives is shown in TABLE XV below
                                             TABLE XV
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B.M.I
SYSTOLIC B.P
MEAN ± S.D
DIASTOLIC  B.P
MEAN ±  S.D
STAGE I 178.5 ±14.43 109.81 ±6.03
STAGE II 149.77 ±6.92 95.54 ±1.985
                  Risk factors among cases and controls
TABLE XVI
smoking Alcohol both Family history
yes no yes No Yes No
Cases 24 46 11 59 10 12 58
Controls 14 16 5 24 5 2 28
The  risk  factors  like  smoking  alcoholism  and  family  history  of  any 
cardiovascular  disease  were  equally  seen  among  cases  and  controls  this  is 
shown in TABLE XVI above (FIG – 4)
FIG – 4
Risk factors among cases and controls
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Risk factors among stage I and stage II hypertensives
                                       TABLE XVII
smoking Alcohol Both Family history
yes no yes No Yes No
stage I 10 16 4 21 4 3 23
stage II 14 30 7 38 5 9 35
The above TABLE XVII shows the prevalence of risk factors among stage I and 
stage II hypertensives .This shows no significant difference.
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Serum sodium among cases and controls
The  Table  XVIII  below  shows  the  mean  and  standard  deviation  of  serum 
sodium among cases and control. (FIG – 5)
TABLE XVIII
Serum sodium Cases Controls
Mean 141.80 138.96
S.D 2.91 2.59
P = 0.00001
                                                                                         
The  serum  sodium  level  was  significantly  more  among  hypertensives  than 
controls. (P value = 0.00001)
Serum sodium among stage I and stage II hypertensives
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The Table XIX shows the mean and standard deviation of serum sodium among 
stage I and stage II hypertensives (FIG – 6)
TABLE XIX
Serum  sodium stage I stage II
Mean 140.73 142.43
s.d 2.539 2.96
P = 0.017
 FIG – 5
Serum sodium among cases and controls
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                                                 FIG – 6
Sodium among stage I and stage II hypertensives
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The serum sodium level was significantly higher among stage I hypertensives 
than stage II hypertensives. (P value = 0.017).
Serum sodium among males and females
TABLE XX
Serum sodium Cases Controls
Males 141.84±3.063 138.95±2.982
Females 141.75±2.782 139±1.7
P value 0.89 0.96
                                   The table above shows the serum sodium values among  
males  and  females  in  both  cases  and  control  group.  The  statistical  analysis 
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showed  no  significant  difference  in  serum sodium  levels  among  cases  and 
controls with respect to their gender.
Serum potassium among cases and controls
The table below shows the mean and standard deviation of serum potassium 
among cases and control (FIG -7).
                                              TABLE XXI
Serum potassium Cases Controls
Mean 3.86 4.013
S.D 0.197 0.196
P= 0.00004
The  serum  potassium  level  was  significantly  more  among  controls  than 
hypertensives.(P VALUE = 0.00004)
FIG – 7
Serum potassium among cases and controls
54
3.75
3.8
3.85
3.9
3.95
4
4.05
CASES CONTROLS
S.POTASSIUM
S.POTASSIUM
S. potassium among stage I and stage II hypertensives
The table shows the mean and standard deviation of serum potassium among 
stage I and stage II hypertensives.        
TABLE XXII
Serum Potassium Stage I Stage II
Mean 3.86 3.85
S.D 0.22 0.18
P = 0.83
S. Potassium among males and females
                                          This Table XXIII shows the serum sodium values 
among  males  and  females  in  both  cases  and  control  group.  The  statistical 
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analysis  showed  no  significant  difference  in  serum potassium levels  among 
cases and controls with respect to their gender.
TABLE XXIII
Serum potassium Case Control
Male 3.86 ± 0.19 4.05±0.20
Female 3.86±0.20 3.95±0.17
P value 0.98 0.21
Twenty four hour Urine sodium excretion among cases 
and controls
                    The Table XXIV below shows the mean and standard deviation of 
urine   sodium among cases and control. (FIG - 8)
                                        TABLE XXIV
Urine sodium Cases Controls
Mean 232.89 188.10
S.D 70.15 47.04
P=0.001
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                       The main aim of our study is to study twenty four hour Urine 
sodium among cases  and controls.  The urine sodium level  was significantly 
more among hypertensives than controls. (P = 0.001)
FIG -8
Twenty four hour Urine sodium excretion among cases 
and controls
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Twenty four hour Urine sodium excretion among
Stage I and Stage II hypertensives.
The Table XXV below shows the mean and standard deviation of urine sodium 
among Stage I and Stage II hypertensives (FIG – 9)
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FIG – 9 
Twenty four hour Urine sodium excretion among Stage I 
and Stage II hypertensives.
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Urine sodium Stage I Stage II
Mean 208.92 247.04
S.D 59.64 72.64
P value =0.027
 
The urine sodium level was significantly higher among stage I hypertensives 
than stage II hypertensives. 
Twenty four hour Urine sodium excretion with respect to gender
                    This Table XXVI shows the serum sodium values among males and 
females  in  both cases  and control  group .The  statistical  analysis  showed no 
significant  difference in serum sodium levels among cases and controls with 
respect to their gender.
                                             TABLE XXVI
Urine sodium Case Control
Male 231.42 ± 70.67 178.95  ± 48.36
Female 234.72  ± 70.62 206.40 ± 40.44
P value 0.84 0.33
Twenty four hour urine potassium excretion among cases 
and controls
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               The Table XXVII   below shows the mean and standard deviation of 
urine potassium among cases and control.
TABLE XXVII 
Urine potassium Cases Control
Mean 45.76 51.83
s.d 18.91 17.39
P Value = 0.13
The urine potassium level was not significantly lower among hypertensives than 
controls. 
FIG -10
Twenty four hour urine potassium excretion among cases 
and controls
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            The urine potassium level was not significantly higher among stage I 
hypertensives than stage II hypertensives as shown in table below
                                       TABLE XXVIII
Urine potassium Stage I Stage II
Mean 46.73 45.18
s.d 20.74 17.96 P value = 0.74
Twenty four hour urine potassium excretion with respect 
to gender
                  This Table XXIX shows the urine potassium values among males 
and females in both cases and control group. The statistical analysis showed no 
significant difference in urine potassium levels among cases and controls with 
respect to their gender.                    
                                          TABLE XXIX
Urine potassium Case Control
Males 46.10 ± 19.24 50 ± 18.63
Females 45.34 ± 18.81 45.16 ± 18.41
P value 0.86 0.50
Analysis of sodium and potassium in serum and urine with 
respect to their Body Mass Index [B.M.I]
             The Table below shows the mean and standard deviation of sodium and 
potassium in serum and urine with respect to their Body Mass Index [B.M.I] 
(FIG 19 AND FIG 20).
62
                                          TABLE XXX
PARAMETER Low B.M.I High B.M.I P value
Serum sodium 140.74 ± 2.93 142.46 ± 2.74 0.01
Serum potassium 3.88 ± 0.22 3.84 ± 0.18 0.53
Urine sodium 227.03 ± 71.70 236.56 ± 69.75 0.58
Urine potassium 46.48 ± 19.83 45.30 ± 18.52 0.80
 
For this analysis we compare cases with body mass index < 23(low B.M.I) with 
cases having body mass index ≥ 23(high B.M.I).
                                     The statistical analysis of sodium and potassium levels in 
serum and urine with respect  to their  body mass index [B.M.I]  showed that 
there is significantly high serum sodium in cases with high body mass index 
than cases with low body mass index. The levels of serum potassium, urine 
sodium and  urine  potassium does  not  differ  significantly  among  cases  with 
higher and lower body mass index.
Analysis of sodium and potassium in serum and urine with 
respect to their body mass index among controls
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The table below shows the mean and standard deviation of sodium and 
potassium levels in serum and urine with respect to their B.M.I among controls.
TABLE XXXI
PARAMETER Low B.M.I High B.M.I P value
Serum sodium 138.60=-2.55 140.14=-0.20 0.17
Serum potassium 4.04=-0.20 3.93=-0.16 0.16
Urine sodium 180.13=-42.49 200.28=-60.44 0.32
Urine potassium 52.39=-15.95 50=-22.86 0.75
There was no statistically significant difference in sodium and potassium levels 
in serum and urine among controls.
DISCUSSION
                    Essential hypertension comprises 90% of all hypertensive patients.1 
various  factors  have  been  responsible  for  perpetuation  or  causation  of 
hypertension. In addition to hereditary predisposition, high sodium intake and 
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lower potassium intake and excretion may also contribute to the development of 
hypertension  which  has  been  proved.3 Excretion  of  sodium  and  potassium 
depend on their intake. Positive correlation between salt excretion and blood 
pressure has been proved by some and disproved by other recent studies.66, 67 
                 Present study was conducted to clear this controversy in a population 
who have habit of excessive salt intake in the form of sea foods like dry fish, 
pickles and even the water they use have high sodium due to nearness to sea.
                       In the Chennai Urban Rural Epidemiology Study (CURES) 68 an 
ongoing population based study on a representative population of Chennai city 
in southern India, mean dietary salt intake (8.5 g/d) in the population was higher 
than the recommended by the World Health Organization (<5g/d).
                        Our study population is also from Chennai city. In our study we 
analysed serum sodium, serum potassium, urine sodium and urine potassium 
(twenty four hour collection) among newly diagnosed hypertensives. Primary 
aim of our study is to compare 24 hour urine sodium excretion in hypertensives 
and normotensives and also to study with respect to their body mass index and 
stages of hypertension. 
                    The varsity of hypertension among those consuming large amount 
those  consuming  large  amount  of  salt  may  probably  be  related  to  chronic 
adaptation of body system towards renal clearance of sodium.
SERUM SODIUM AMONG HYPERTENSIVES
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                      In our study serum sodium was estimated in control and study 
groups and compared between them. Results were compared with other studies. 
Serum sodium was higher in the hypertensive group than the control group even 
through both were within the normal range. 
                                     The mean and standard deviation of serum sodium 
among cases was 141.80 ± 2.91 while in the control group was 138.96 ± 2.59 
respectively [p=0.00001]. Our study was supported by RA Jan, et al (2006)69, 
Srinagar, Kashmir. In this study 135 hypertension patients and equal number of 
age and sex matched healthy controls were taken for the study. Serum sodium in 
the hypertension group was 140 ±2.90 while in the control group it was found to 
be 138.5±1.12. Serum sodium was higher in the hypertension group than the 
control  group  and  considered  to  be  a  factor  responsible  for  causation  of 
hypertension.
          In our study the mean and standard deviation of serum sodium among 
stage  1  and  stage  2  hypertensives  were  140.73  ±  2.54  and  142.43  ±  2.96 
respectively[p=0.017].The serum sodium level was significantly higher among 
stage II hypertensives than stage I hypertensives. This was also supported by 
RA Jan, et al (2006), Srinagar, Kashmir.
           A study was carried out by Lever et al of arterial pressure and body 
content of electrolytes in 91 patients with essential hypertension and 121 normal 
control  70.Plasma  and  exchangeable  sodium  was  found  to  be  positively 
correlated with arterial pressure in the patients.                                       
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                    In another study conducted by Williams et al, they studied the 
relationship  of  body  sodium,  chlorine  and  potassium  in  30  patients  with 
essential  hypertension.  They found that  a  positive correlation exists  between 
serum sodium and blood pressure in this study group71.
                  In another study conducted by Bulpitt, two thousand three hundred 
and  28  men  and  1496  women  between  the  ages  of  35  and  64  years  were 
screened  for  hypertensive  and  other  plasma  sodium  and  its  concentration 
measured. It was found that plasma sodium was positively related to that of 
blood pressure and an increased in serum sodium of 1mmol/l  was associated 
with an increase of 1mmol hg in both men and women72.
SERUM POTASSIUM AMONG HYPERTENSIVES
                   In our study serum potassium was estimated in control and study 
groups and compared between them. Serum potassium was found to be lower in 
the hypertensive group when compared with control group even though both 
were within normal range.
                       The mean serum potassium in study group was 3.86±0.197.The 
mean potassium in the control  group was 4.013±0.196.  [p=0.00004].  This  is 
statistically significant. There was no significant difference among the 2 stages 
of hypertension.
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                  A study was carried out by Bulpitt et al among two thousand three 
hundred and twenty eight men and 1496 women between the ages of 35 and 64 
years,  a  decrease  in  plasma  potassium  of  1mmol  was  associated  with  an 
increase  in  systolic  pressure  in  women  of  7mmHg  (p  less  than  0.001)  and 
diastolic  pressure  of  4mmHg  (p  less  than  0.001).  In  men  corresponding 
increases were 4mmHg (p<0.01) and 2mmHg (p<0.05)72
                                       Similarly in a study conducted by Lever et al 70 in  121 
normal  subjects  and  91  hypertensive  patients  it  was  shown  that  plasma 
exchangeable  on  a  total  body  potassium  correlated  inversely  with  arterial 
pressure in the patients. They suggested the following theory as the cause of 
essential hypertension.
                  In the early stages of the disease blood pressure is raised by an 
abnormal process related more closely to potassium than to sodium. A renal 
lesion develops later possibly as a consequence of the hypertension. This lesion 
is  characterised  by  resetting  of  pressure  natriuresis  and  is  manifest  by  an 
abnormal  relation  between  body  sodium  and  arterial  pressure  and  by 
susceptibility to increased dietary sodium intake.
              Similarly a study was conducted at national institute of public health 
and  environmental  protection,  Bilthoven,  the  Netherlands,  the  relationship 
between the serum cations sodium, potassium, calcium, magnesium and blood 
pressure were investigated in a population  based sample of 182 Dutch persons 
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aged 20-59 years. In the combined analysis, a weak inverse relationship was 
found between serum potassium and diastolic blood pressure. 73
        In an another study carried out at Karachi,  Pakistan 30 hypertension 
diabetic patients and equal number of age and sex matched controls were taken 
for  the study.he mean serum potassium was 4.59 mmol/l  among the control 
group74.
                      To investigate the role of potassium on blood pressure luft et al 
conducted  a  study  among  431  normotensive  and  478  hypertensive  subjects. 
They  observed  an  inverse  relationship  between  serum potassium  and  blood 
pressure supporting our study.75
24 HOUR URINE SODIUM AND HYPERTENSION
    In our study the mean and standard deviation for 24 hour urine sodium in 
cases and control were232.89±70.15 and188.10 ± 47.04 [p= 0.001].  The mean 
and  standard  deviation  for  24  hour  urine  sodium  in  stage  1  and  stage  2 
hypertensives were 208.92± 59.64 and 247.04 ±72.64[p=0.027].
                      So there was a statistically significant increase in sodium 
excretion among hypertensives which was more with increased blood pressure 
[more in stage II than stage I hypertensives] 
                     This observation was supported by RA Jan, et al69 (2006), 
Srinagar, Kashmir. In that study the mean and standard deviation for 24 hour 
urine sodium excretion was very high among both hypertensives and normal 
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subjects 424 ± 150.50 and 337 ± 121.50 respectively (p < .001).This was due to 
high intake of salt tea in that population (average 27 g/day) consistent with a 
studies done in Japan (average 11-27 g/day).76,77
                         Excessive 24 hr urinary sodium excretion has been seen in other 
studies as well.7879
                         In a study conducted by Tuomilehto et al80, a 24-hour urine 
collection was carried out during a cardiovascular survey in eastern Finland. The 
study population comprised 148 hypertensive subjects in a random sample of 
the middle-aged population and 86 normotensive controls.  The mean sodium 
excretion was  197  mmol  /24h  in  normotensive  and  hypertensive  men, 179 
mmol/24h  in  normotensive  women,  and  174  mmol  /24h  in  hypertensive 
women.The results of this study show that the average level of salt intake in a 
Finnish  population  is  high,  and  so  is  the  sodium:  potassium molar  ratio. 
Although there was no correlation between sodium excretion and blood pressure 
levels, it  is known that in this population the average blood pressure level is 
high and cardiovascular disease extremely frequent. 
                            Intersalt3 found significant positive relations between 24 hour 
urinary sodium excretion and systolic and diastolic blood pressure in individual 
participants  and  between  individual  urinary  sodium to  potassium ratios  and 
blood pressure.
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                   Statistically significant increased 24 hr excretion of sodium in 
hypertensives  in  our  study  was  possibly  responsible  in  causation  of 
hypertension which was in agreement to various other studies.81-83 
                             Sensitivity to hypertensive effect of sodium may be  
genetically determined which may be also operative in our cases as well.84 It is 
also  supported  by  fact  that  hypertension  decreased  by  low  salt  intake  and 
hypertension  is  absent  or  rare  in  population  with  low salt  intake  as  is  the 
antihypertensive  effect  of  thiazides  due to  loss  of  sodium and extra  cellular 
fluid.83, 85, 86
24 HOUR URINE POTASSIUM AND HYPERTENSION
                   Though the main aim of our study is to compare 24 hour urine 
sodium excretion in hypertensives and controls we also analysed 24 hour urine 
potassium levels in hypertensives and normal.
                            In our study the mean and standard deviation for 24 hour urine 
potassium in cases and control were 46.75±18.91 and 51.83±17.39 [p= 0.13]. 
the mean and standard deviation for 24 hour urine potassium in stage 1 and 
stage 2 hypertensives were 46.73±20.74 and 45.18±17.96 [p=0.74].
                         In both hypertensives and normotensives, average 24 hour 
urinary excretion of potassium was lower because of low intake of potassium in 
this part of world which might also contribute to hypertension as has also been 
seen by Menealy and Belarbee in 1976.81 
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               Low potassium intake leading to increase blood pressure and vice 
versa is confirmed by various other studies independent of sodium excretion.81,87 
Recently there was evidence of additive effect of high sodium intake and low 
potassium intake in causation of hypertension which may be operative in our 
hypertensive group as well. 
BODY MASS INDEX AND HYPERTENSION.
         In our study the mean body mass index among the study group was 24 ± 
3.15  and  among  the  control  group  was  21.3±2.14.the  “p”  value  was 
0.00004.This  shows  that  overweight  and  obesity  also  plays  a  role  in  the 
development of essential hypertension.
                  This was supported by a study conducted by Stamler51.  They 
showed that the hypertension is about six times more common in obese than it is 
in lean subjects. The present study concurs with above observation. 
                        Similarly a study conducted by Huang stated that even a small 
amount of weight gain is associated with a marked increase in the incidence of 
hypertension88.  This  study showed a positive correlation between body mass 
index and blood pressure which supported our study.
                                           In INTERSALT 89, the relationship between body 
masss index(kg/m^2) and blood pressure was studied in 10,079 men and women 
aged 20-59, sampled from 52 centres around the world, based on a standardized 
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protocol with central training of observers, a central laboratory and extensive 
quality control.  Body mass index and blood pressure relationships were first 
studied in men and women within each centre and results of these regression 
analyses were then pooled for all 52 centres, with adjustment for age, alcohol 
intake,  smoking,  sodium  and  potassium  excretion,  body  mass  index  was 
positively associated with systolic blood pressure in some centres and diastolic 
blood pressure in some centres. In further analyses across centres median body 
mass  index  related  significantly  to  median  systolic  blood  pressure,  median 
diastolic  pressure  and  prevalence  of  hypertension  in  both  men  and  women. 
Body  mass  index  was  related  to  the  slopes  of  systolic  and  diastolic  blood 
pressure with age in women but not in men.
                           In our study the mean and standard deviation for serum sodium 
levels  among  cases  with  low and  high  body  mass  index  were  140.74±2.93 
and142.46 ±2.74 respectively which was statistically significant[p=0.01]. The 
mean and standard deviation of urine sodium among cases with low and high 
body mass index were 227.03±71.70 and 236.56 ± 69.75 respectively. Although 
sodium excretion seems to be high in cases with higher body mass index this 
was not statistically significant [p=0.58].
              So raised body mass index have played a significant role in increased 
serum sodium seen in hypertensives, but the role played by body mass index in 
increased sodium excretion seen among hypertensives were  insignificant.  
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                     A study conducted by Jan et al 69observed significant impact of 
BMI on 24 hr Na+ excretion in both groups with increased sodium excretion 
with high BMI while there was no association of BMI with K+ excretion in 
either group. 
                              Relationship of BMI with Na+ output and hypertension has 
been proved by Sampson et al in 197890. BMI showed no significant influence 
on Na+ excretion in hypertension patients in our study but while estimation 
BMI should always be considered. 
                         Age modifies  a number  of factors  i.e.,  GFR, renal 
hemodynamics  and  responsiveness  of  renin  angiotensin  aldosterone  system 
confirmed  by Norma  K Hollenberg  as  well.  Age influences  the  capacity  of 
kidneys to conserve sodium, so age related changes must be considered while 
estimations.91
            In our study we did not attempt to study the age related differences in 
sodium excretion because  our  subjects  fall  within a  smaller  group 40 to  60 
years.        
             Also in our study there was no statistically significant difference in 
sodium excretion among males and females.
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                               CONCLUSION
 The following conclusions were derived from our study.
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1) Serum sodium was significantly more among hypertensives and was also 
correlated positively with the level of blood pressure. It was independent 
of associated risk factors and gender.
2) Serum  potassium  was  significantly  less  among  hypertensives  and  it 
correlated negatively with blood pressure. 
3)Markedly  increased  24  hour  sodium  excretion  and  low  potassium 
excretion in hypertensive group indicates a very high intake of sodium 
and low intake of dietary potassium both playing significant individual as 
well as additive role in causation or perpetuation of hypertension. 
4)Body mass index has direct bearing on blood pressure but not on sodium 
excretion.
5)In  view of  significant  changes  in  simple  electrolyte  levels  (sodium & 
potassium)  among  hypertensive  population,  community  must  be 
motivated  to  reduce  their  intake  of  common  salt  and  encouraged  to 
consume  potassium  rich  nutrients-diets  as  a  form  of  prevention  for 
essential hypertension.
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PROFORMA
NAME  :                               AGE:                SEX:      F/M    
DIET   :      V/NV
ADDRESS:                                          OCCUPATION:
SYMPTOMS:
Headache                       Oliguria                           Giddiness
Puffiness of face           Blurring of vision           Epistaxis
Swelling of legs              Anorexia                        Chest pain
Vomiting/hiccups          Palpitation                      Easy fatiguability
Dyspnoea                       Polydipsia                      Polyuria
PAST HISTORY
Diabetes mellitus                      Angina/MI                  Heart failure
Renal disorders                         PVD                            Stroke
PERSONAL HISTORY
Smoking                                     Alcohol                     Drug abuse
FAMILY HISTORY
Hypertension                          Diabetes mellitus
ANTHROPOMETERY
Wt ( kg)                        Ht (cm)                   B.M.I (Kg/m2)
Hip (cm)                       waist (cm)               WHR
GENERAL EXAMINATION
 Fundus  
 Pulse rate                                                 
Blood pressure (mm/hg) =     1)                                2)                               3)
Mean of 3 readings =          
                                                      Supine                Sitting
Staging of hypertension
Pedal edema                   
SYSTEMIC EXAMINATION
C.V.S =
R.S =
P/A =
INVESTIGATION 
URINE
Albumin 
Sugar
Deposits
Blood glucose
Serum urea 
Serum Creatinine
Serum sodium = 
Serum potassium =
TWENTY FOUR HOUR URINE
         Volume =
         Creatinine=
         Sodium =
         Potassium = 
         Protein =    
ECG
ULTRASOUND   ABDOMEN
CHEST X-RAY PA VIEW
MASTER CHART
S.N
O NAME
A
G
E
SEX
SYM
PTO
M
P/H
SM
O
K
IN
G
A
LC
O
H
O
L
F/H B.M.I
Kg/m2
S.B.P
mm/H
g
D.B.P
mm/H
g
FU
N
D
U
S
S.
E
B
.G
LU
C
O
S
E
B
.U
R
EA
S.C
R
EATIN
I
N
E
S.SO
D
IU
M
S.PO
TASSI
U
M
E.C
.G
C
.X.R
U
SG
.A
B
D
1 PANDURANGAN 58 M 1 N Y Y N 26.7 154 94 N N 85 38
1.
1 138
3.
8 H N N
2 ARPUTHAM 54 F 2 N N N N 25.8 156 110 N N 78 26 1 145 3.8 N N N
3 MALLIKA 55 F 2 N N N N 25.9 148 94 N N 80 26 0.9 140
4.
3 N N N
4 SAROJA 58 F 1 N N N N 22.4 154 98 N N 82 36 0.8 142
3.
9 N N N
5 BALARAMAN 52 M 2 N Y N B 22.1 156 94 N N 132 54 1 143
4.
3 N N N
6 VIJAYA 60 F 3 D N N D 28.7 158 98 N N 138 52
1.
1 144
3.
6 N N N
7 DAMODARAN 52 M 4 N Y N N 23.8 156 98 N N 86 38 0.9 142
4.
2 L N N
8 RAJENDRAN 49 M 1 N Y Y N 29.5 158 96 N N 70 24 0.8 143
3.
8 N N N
9 IQBAL 59 M 2 N N N N 26.9 142 98 I N 72 32 0.8 142
3.
6 N N N
10 ELUMALAI 46 M 4 N Y N Y 17.3 164 100 N N 76 24 0.9 137
3.
7 N N N
11 JAYARAMAN 57 M 2 D Y Y N 21.1 182 120 N N 134 48
0.
9 145
3.
9 N N N
12 SELVAKUMAR 59 M 2 N N N N 25.4 180 110 N N 78 24
0.
9 143
3.
6 N N N
13 NAGOORKANI 53 F 4 N N N N 25.8 186 110 N N 68 44
0.
8 144
3.
8 L N N
14 AMARAN 56 M 3 N Y N Y 23.8 186 104 N N 76 24 0.6 136
3.
7 L C N
15 MUNIYAMMAL 55 F 1 N N N N 24.2 130 96 N N 90 35
0.
9 142
4.
2 N N N
16 JAYALAKSHMI 46 F 1 N N N N 25.6 154 96 N N 98 32 1 143 4 N N N
17 MUTHU 48 M 1 N N N N 20.9 154 96 N N 88 34 0.9 139
3.
7 N N N
18 MARIYAMMAL 46 F 4 N N N N 18.1 176 104 N N 65 29 1 144
3.
7 N N N
S.N
O NAME
U.VOLUME(
ml)
U.PROTEIN
(mg/24 hrs)
U.CREATININE
(mg/24hrs)
U.SODIUM
(mg/24hrs)
U.POTASSIUM
(mg/24 hrs)
1 PANDURANGAN 1650 67 1291 240 76
2 ARPUTHAM 1600 67 1454 325 75
3 MALLIKA 1500 77 1133 130 41
4 SAROJA 1450 54 1064 252 67
5 BALARAMAN 1450 48 1527 254 21
6 VIJAYA 1750 50 929 240 74
7 DAMODARAN 1500 64 1544 138 20
8 RAJENDRAN 1250 64 1705 267 56
9 IQBAL 1150 75 1395 232 68
10 ELUMALAI 1200 56 1878 172 59
11 JAYARAMAN 1650 71 1429 224 56
12 SELVAKUMAR 1350 49 1701 173 26
13 NAGOORKANI 1300 37 820 166 39
14 AMARAN 1350 52 1310 284 41
15 MUNIYAMMAL 1200 31 900 186 61
16 JAYALAKSHMI 1300 61 937 156 26
17 MUTHU 1650 60 1757 264 43
18 MARIYAMMAL 1250 68 1171 125 59
S.N
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G
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M
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S.B.P
mm/H
g
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g
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N
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R
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E
S.SO
D
IU
M
S.PO
TA
SSIU
M
E.C
.G
C
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U
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.A
B
D
19 SAROJA 45 F 5 N N N N 23.8 176 109 N N 83 22 0.7 144 4 N N N
20 SARIKA 44 F 2 N N N N 23.1 174 106 N N 68 28 0.8 141
3.
9 N N N
21 SARASA 48 F 4 N N N N 25.2 156 94 N N 90 34 0.9 142
3.
6 N N N
22 AMBIKA 56 F 1 N N N N 26.6 178 106 N N 77 22 0.8 136
4.
2 N N N
23 ALAGAMMA 59 F 4 N N N D 26.6 188 100 N N 76 22 0.9 141
3.
6 N N N
24 MUTHU 55 M 1 N Y N N 17.4 140 92 N N 80 36 0.8 140
3.
6 N N N
25 SELVAM 51 M 1 N N N N 18.1 158 114 N N 81 25 0.9 143
3.
8 N N N
26 MOORTHY 57 M 1 N Y Y Y 20.2 158 110 N N 72 34 08 140 4.2 H N N
27 AYISHA 57 F 1 N N N N 17.3 162 102 N N 88 36 0.7 143
3.
7 N N N
28 BASHEERA 57 F 1 N N N N 25.4 178 100 N N 86 26 0.8 143
3.
6 N N N
29 KAMATCHI 60 F 2 N N N Y 23.8 180 108 N N 88 28 1.2 143
3.
7 N N N
30 RAJA 60 M 4 N Y N N 23.1 188 106 N N 82 34 1.1 141
3.
9 N N N
31 GOVINDASAMY 56 M 1 N Y Y N 26.6 168 109 N N 83 20 0.9 144
3.
6 N N N
32 KANNAN 55 M 1 N N N N 20.4 168 120 N N 69 28 0.9 139
3.
9 N N N
33 KAMALA 52 F 3 N N N Y 26.8 200 120 N N 96 22 0.8 143
3.
8 N N N
34 AKBAR 54 M 4 N Y N N 26.3 164 120 N N 88 21 1.1 147
3.
9 N N N
35 SUDHAKAR 51 M 4 N N N N 28.8 168 108 N N 69 26 0.8 142
3.
9 L C N
36 NAGAMMAL 55 F 2 N N N N 20.2 182 102 N N 94 34 1 146 3.6 N N N
S.
NO NAME
U.VOLUM
E
(ml)
U.PROTEI
N
(mg/24 
hrs)
U.CREATININ
E
(mg/24hrs)
U.SODIUM
(mg/24hrs)
U.POTASSIUM
(mg/24 hrs)
19 SAROJA 1200 55 1312 287 77
20 SARIKA 1350 57 1036 166 60
21 SARASA 950 34 1211 240 29
22 AMBIKA 1350 39 1206 187 33
23 ALAGAMMA 1600 75 1097 297 31
24 MUTHU 1450 47 1464 206 53
25 SELVAM 1450 40 1627 289 76
26 MOORTHY 1450 55 1547 258 27
27 AYISHA 1650 57 1259 219 60
28 BASHEERA 1350 42 1162 248 30
29 KAMATCHI 2200 48 957 123 55
30 RAJA 2250 79 1502 177 48
31 GOVINDASAMY 1350 46 1504 332 32
32 KANNAN 1250 72 1672 273 26
33 KAMALA 1050 63 1050 243 25
34 AKBAR 1750 84 1694 321 66
35 SUDHAKAR 1250 14 1060 253 27
36 NAGAMMAL 1400 49 1056 335 26S.N
O
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E
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M
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SM
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K
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A
LC
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O
L
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37 VASANTHA 60 F 3 N N N N 28.9 158 94 N N 73 32 1.1 14
3
3.8 N N N
38 SEKAR 60 M 2 N Y N Y 26.5 172 114 N N 78 34 0.9 14
6
3.7 N N N
39 PUSHPA 59 F 1 N N N N 21.6 168 108 N N 10
5
26 0.8 14
5
4 N N N
40 CHANDRAN 55 M 2 N N N N 20.2 172 112 N N 74 32 1 13
9
4.3 N N N
41 AMEERA BEE 58 F 2 N N N N 28.1 210 120 I N 78 34 0.8 14
5
3.9 N N N
42 DURAI 54 M 2 N N N N 25.7 190 114 N N 98 32 1 14
4
4 N N N
43 THANMANI 54 F 4 N N N Y 20.4 170 110 N N 80 24 1 13
9
3.9 N N N
44 SOUNDARAM 56 F 2 N N N N 20.2 192 106 N N 97 26 0.6 14
2
4.3 N N N
45 SUDHAKAR 44 M 1 N N N N 24.9 166 106 N N 90 26 0.6 14
3
3.7 N N N
46 DHANABACKIY
AM
50 F 3 N N N N 29.7 186 108 N N 93 24 0.8 14
6
3.7 N N N
47 MANI 60 M 2 N Y N N 25.8 156 108 N N 80 36 1.2 14
4
3.8 L C N
48 KUMAR 45 M 1 N N N N 18.8 166 104 N N 70 26 0.6 14
2
4.1 N N N
49 CHANDRAN 59 M 2 D N N N 29.9 190 116 N N 12
8
46 0.9 14
4
3.7 L N N
50 MANI 60 M 2 N Y Y N 27.6 178 108 I N 91 29 0.9 14
5
3.6 L N N
51 CHITTIBABU 52 M 3 N N N Y 22.6 188 112 N N 91 34 0.9 14
5
3.8 N N N
52 DURAIRAJ 53 M 5 N Y Y N 29.1 210 120 N N 63 42 0.9 14
6
3.9 N N N
53 MOIDEEN 50 M 2 N Y N N 25.8 194 118 N N 10
0
23 0.7 13
7
3.8 N N N
54 GOPAL 58 M 3 N Y Y N 29.6 208 120 N N 74 42 0.8 14
7
4 L C N
S.N
O NAME
U.VOLUME(
ml)
U.PROTEIN
(mg/24 hrs)
U.CREATININE
(mg/24hrs)
U.SODIUM
(mg/24hrs)
U.POTASSIUM
(mg/24 hrs)
37 VASANTHA 1700 71 1103 316 24
38 SEKAR 1650 63 1752 191 74
39 PUSHPA 1200 54 1319 328 27
40 CHANDRAN 1250 71 1792 342 38
41 AMEERA BEE 1500 48 1229 338 66
42 DURAI 1650 72 1712 268 24
43 THANMANI 1350 74 1195 286 24
44 SOUNDARAM 2000 53 1202 172 45
45 SUDHAKAR 1150 44 1283 276 55
46 DHANABACKIYAM 1150 66 970 283 34
47 MANI 1850 59 1237 172 63
48 KUMAR 1400 69 1580 112 72
49 CHANDRAN 1550 42 1304 310 34
50 MANI 2250 26 1222 334 24
51 CHITTIBABU 1250 101 1441 308 25
52 DURAIRAJ 1400 66 1636 126 62
53 MOIDEEN 1450 56 1973 217 35
54 GOPAL 1750 60 1579 339 68
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G
E
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55 SANTHA 60 F 2 N N N N 27.5 182 110 N N 92 36 1.1 140 3.9 N N N
56 JOTHI 55 F 3 N N N N 21.1 202 108 N N 78 36 1 140 4 N N N
57 MANI 53 M 1 N Y N B 27.5 176 102 I N 124 44 0.9
14
0 4 N N N
58 DEVI 46 F 3 N N N N 19.9 150 96 N N 84 20 0.9 138 3.8 N N N
59 GOPAL 50 M 1 N Y Y N 23.1 148 98 N N 68 22 0.8 143 3.9 N N N
60 SUSEELA 50 F 2 N N N N 27.3 146 92 N N 100 20 0.9
13
9 3.9 N N N
61 VIJAYA 51 F 1 N N N N 25.7 158 110 N N 76 27 0.6 138 3.9 N N N
62 SAROJA 47 F 2 N N N N 19.1 146 92 N N 92 24 0.7 137 4 N N N
63 PERUMAL 53 M 1 N N N Y 27.1 146 96 N N 105 24 0.8
14
2 3.9 N N N
64 ISMAIL 44 M 2 N N N N 21.9 140 94 N N 93 22 0.7 137 3.6 N N N
65 SHANTHI 55 F 2 N N N N 19.7 148 94 N N 76 24 0.9 136 3.6 N N N
66 KRISHNAN 53 M 4 N Y N Y 28.8 156 98 N N 62 26 0.7 145 4 N N N
67 DHANRAJ 59 M 1 N Y N N 21.1 146 96 N N 77 28 0.7 138 4 N N N
68 MANOHAR 55 M 1 N Y Y N 21.9 146 96 N N 85 34 0.8 142 3.9 N N N
69 RAJENDRAN 43 M 1 D Y N N 22.9 148 96 I N 121 54 1
13
7 3.7 N N N
70 KAMALA 57 F 4 N N N N 20.9 156 98 N N 73 32 0.8 142 3.7 N N N
71 PALANI 45 M 0 N N N N 18.9 90 70 N N 115 22 0.8
14
1 4.4 N N N
72 SELVAM 46 M 0 N N N N 23.7 98 69 N N 64 22 0.8 144 4.2 N N N
S.N
O NAME
U.VOLUME
(ml)
U.PROTEIN
(mg/24 hrs)
U.CREATININE
(mg/24hrs)
U.SODIUM
(mg/24hrs)
U.POTASSIUM
(mg/24 hrs)
55 SANTHA 2000 63 1136 332 63
56 JOTHI 1250 55 1016 313 41
57 MANI 1250 78 1641 120 36
58 DEVI 1200 38 1258 204 38
59 GOPAL 1400 44 1604 132 35
60 SUSEELA 1400 50 1176 229 34
61 VIJAYA 1350 92 927 226 24
62 SAROJA 1450 35 1160 138 25
63 PERUMAL 1200 53 1388 226 22
64 ISMAIL 1450 45 1711 132 61
65 SHANTHI 1500 64 1120 136 84
66 KRISHNAN 1350 44 2003 326 55
67 DHANRAJ 1050 80 1585 135 25
68 MANOHAR 1300 55 1452 179 37
69 RAJENDRAN 1500 57 1782 189 86
70 KAMALA 1350 39 1246 285 54
71 PALANI 1350 65 1594 135 69
72 SELVAM 1550 59 1269 247 51
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73 KANDASAM
Y
59 M 0 N Y N N 17.9 101 70 N N 82 56 0.9 13
6
4.3 N N N
74 KALIMA 49 F 0 N N N N 24.4 102 72 N N 89 36 0.9 13
7
4 N N N
75 MALARKODI 52 F 0 N N N Y 22.6 102 72 N N 69 33 0.9 13
9
3.8 N N N
76 MANGALAM 54 F 0 N N N N 20.3 102 72 N N 75 23 0.8 14
0
3.7 N N N
77 ABDUL 49 M 0 N Y Y N 23.9 109 69 N N 10
3
32 1 14
0
3.8 N N N
78 KAVERI 48 F 0 N N N N 26.4 110 69 N N 66 34 0.8 14
0
3.7 N N N
79 USHA 53 F 0 N N N D 22.2 110 70 N N 96 20 0.8 13
8
4 N N N
80 UMA 54 F 0 N N N N 19.1 110 70 N N 78 24 0.9 13
8
3.9 N N N
81 PAKKIRI 48 M 0 D Y N D 17.7 110 70 N N 13
2
60 1.1 13
5
3.8 N N N
82 MURUGAN 48 M 0 N Y Y N 21.2 110 80 N N 66 32 0.6 13
8
4 N N N
83 MANI 48 M 0 D Y N N 23 110 70 N N 13
3
54 0.6 13
9
3.9 N N N
84 MADAN 56 M 0 N N N N 20.5 110 70 N N 96 22 0.8 13
7
4.1 N N N
85 KRISHNAN 56 M 0 N Y Y N 22.9 110 70 N N 10
8
21 0.8 14
2
4.1 N N N
86 MOORTHY 58 M 0 N Y N N 19.3 110 70 N N 11
0
24 0.9 13
6
4.1 N N N
87 AVITTAN 60 M 0 N Y N N 22 110 70 N N 95 22 1.1 13
6
3.9 N N N
88 ANANDHAN 46 M 0 N N N N 23.2 99 69 N N 90 22 0.9 13
8
3.9 N N N
89 AMBIKA 54 F 0 N N N N 20.9 100 70 N N 68 41 0.9 13
8
4.2 N N N
90 MUNUSAMY 50 M 0 N Y Y Y 22.6 100 60 N N 64 20 0.8 14
5
3.8 N N N
S.N
O NAME
U.VOLUME
(ml)
U.PROTEI
N
(mg/24 hrs)
U.CREATININE
(mg/24hrs)
U.SODIUM
(mg/24hrs)
U.POTASSIU
M
(mg/24 hrs)
73 KANDASAMY 1600 53 1211 128 68
74 KALIMA 1300 47 1383 158 42
75 MALARKODI 1250 46 1087 238 22
76 MANGALAM 1450 59 1391 256 71
77 ABDUL 1300 28 1119 254 79
78 KAVERI 1400 82 927 262 41
79 USHA 1600 47 850 208 48
80 UMA 1200 53 1178 140 61
81 PAKKIRI 1600 47 1269 234 60
82 MURUGAN 1350 70 1483 198 30
83 MANI 1650 46 1434 110 82
84 MADAN 1450 44 1497 164 60
85 KRISHNAN 1350 49 1166 228 54
86 MOORTHY 1300 76 1513 145 37
87 AVITTAN 1450 57 1558 206 22
88 ANANDHAN 1400 59 1648 149 20
89 AMBIKA 1350 56 1254 180 47
90 MUNUSAMY 1650 74 1888 237 55
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91 KAYALVILI 56 F 0 N N N N 22.3 110 70 N N 92 22 0.9 13
8
4.1 N N N
92 PAL VANNAN 58 M 0 N Y N N 21.2 110 80 N N 69 25 0.9 13
9
4.1 N N N
93 FATHIMA 47 F 0 N N N N 20 110 70 N N 67 32 1 14
2
3.8 N N N
94 UMA DEVI 54 F 0 N N N N 20.2 100 70 N N 10
1
43 1 13
9
4.1 N N N
95 SRINIVASAN 60 M 0 N Y N N 19.3 100 72 N N 84 24 1.1 13
6
4.2 N N N
96 SIVA 57 M 0 N N N N 23.3 112 72 N N 90 28 0.7 14
3
4 N N N
97 RAVI 47 M 0 N Y Y N 21.3 112 82 N N 76 26 0.9 13
8
4 N N N
98 RAZA BEE 55 F 0 N N N N 20.5 114 74 N N 11
0
34 0.9 14
3
4.1 N N N
99 MUNIAN 48 M 0 N Y N N 22.7 116 76 N N 97 32 1 13
8
3.9 N N N
10
0
THOMAS 43 M 0 N Y N N 17.3 120 80 N N 91 24 0.8 13
6
4.5 N N N
S.N
O NAME
U.VOLUM
E
(ml)
U.PROTEIN
(mg/24 hrs)
U.CREATININ
E
(mg/24hrs)
U.SODIUM
(mg/24hrs)
U.POTASSIU
M
(mg/24 hrs)
91 KAYALVILI 1400 50 1477 214 55
92 PAL VANNAN 1600 71 1073 186 51
93 FATHIMA 1050 70 1602 153 39
94 UMA DEVI 1150 76 1289 155 68
95 SRINIVASAN 1350 78 1968 151 29
96 SIVA 1600 70 942 222 35
97 RAVI 1000 76 1326 202 58
98 RAZA BEE 1350 49 1583 173 80
99 MUNIAN 1250 54 1099 222 60
100 THOMAS 1250 61 1415 88 61
ABBREVIATION USED IN MASTER CHART
                0 - No symptom
                1 – Giddiness                            S.B.P – Systolic blood pressure
                2 – Headache                           D.B.P –Diastolic blood pressure
                3 - Chest pain
                4 - Palpitation
                5 - Dyspnoea
            Y-yes                   N-normal   
            M-male                F-female
           S.E –systemic examination
            I - Grade I hypertension retinopathy
            L - Left ventricular hypertrophy
            H - LAHB
            C - Cardiomegaly
            D- Diabetes
            B- Both Diabetes and Hypertension
       F/H - Family history
       P/H - Past history
